4.6 Article

Cross-Resistance and Baseline Susceptibility of Brown Planthopper Nilaparvata lugens (Hemiptera: Delphacidae) From China to Cycloxaprid

Journal

JOURNAL OF ECONOMIC ENTOMOLOGY
Volume 111, Issue 5, Pages 2359-2363

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/jee/toy222

Keywords

brown planthopper; cross resistance; baseline susceptibility; cycloxaprid

Categories

Funding

  1. National Natural Science Foundation of China [31501644]
  2. Hunan Provincial Key Laboratory for Biology and Control of Weeds [2015TPC1016]
  3. Scientifc-Innovative of Hunan Agricultural Sciences and Technology [2017JC-01]

Ask authors/readers for more resources

The brown planthopper (BPH), Nilaparvata lugens (Stal) (Hemiptera: Delphacidae), is a serious pest of rice. At present, the application of chemical insecticides is the main control option for this pest. BPH has evolved resistance to various classes of insecticides. Cycloxaprid, a new oxabridged cis-configuration neonicotinoid insecticide, is a (nitromethylene) imidazole analog of imidacloprid. This study focused on the baseline susceptibility to cycloxaprid of 18 field samples of N. lugens collected from nine geographical locations in China, as well as possible cross-resistances between cycloxaprid and other important neonicotinoids in one laboratory-selected resistant strain of N. lugens to imidacloprid. The median lethal concentration (LC50) of cycloxaprid for the 18 samples ranged from 1.26 to 14.90 mg/liter. Furthermore, the cross-resistance studies showed that the imidacloprid-resistant strain exhibited a 27.63-fold resistance to imidacloprid and lower levels of cross-resistance to acetamiprid (16.64-fold), thiacloprid (12.64-fold), and nitenpyram (16.90-fold); however, there was no cross-resistance to cycloxaprid (1.92-fold). These results indicate that cycloxaprid could be an effective alternative insecticide for the management of N. lugens, which is urgently needed to prevent or delay further increases in insecticide resistance in N. lugens.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available